The Effects of Replacing Red and Processed Meat With Quorn on Biomarkers of Gut Health
NCT ID: NCT03944421
Last Updated: 2020-06-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2019-07-03
2020-01-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Replacing Red Meat With Legumes on Biomarkers of Chronic Diseases in Healthy Men (Leg4Life)
NCT04599920
Biomarkers of Processed Meat Intake
NCT03354130
Dissecting the Roles of High-quality Diets and Ultra Processed Foods on Cardiometabolic Health
NCT06749327
Quorn in Community Health Experiment
NCT04773483
Effect of Fruit and Vegetable Intake on Markers of Fruit and Vegetable Consumption
NCT01591057
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Quorn is a product which has a considerable fibre component; thus, the replacement of red and processed meat with Quorn, will not only reduce the amount of compounds implicated to have deleterious effects in the gastrointestinal tract (E.G. haem, nitroso compounds, heterocyclic amines), but will also increase the delivery of fibre into the gastrointestinal system, that may well have an overall positive impact on gut health.
In this study, the participants will consume 240 grams (raw weight) of either red and processed meat, or Quorn each day for a 2 week period, this will be followed by a 4 week period where they will return to their usual dietary habits; before swapping to consume the alternative food (red/processed meat or Quorn) for another 2 week period.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Red and Processed Meat
240 grams (raw weight) of red and processed meat every day for 2 weeks
Red and Processed Meat
Integration of 240 grams (raw weight) of red and processed meat into daily diet for 2 week period.
Quorn
240 grams (uncooked weight) of Quorn every day for 2 weeks
Quorn
Integration of 240 grams (uncooked weight) of Quorn into daily diet for 2 week period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Red and Processed Meat
Integration of 240 grams (raw weight) of red and processed meat into daily diet for 2 week period.
Quorn
Integration of 240 grams (uncooked weight) of Quorn into daily diet for 2 week period.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-50 years.
* Not been diagnosed with colorectal cancer, or adenomas.
* Habitual omnivorous dietary pattern.
* BMI ≥18-30 kg/m2.
* Blood HbA1c \<58mmol/mol (\<6.5%) (not diagnosed with diabetes)
* Fasting total cholesterol\<7.8 mmol/l
* Triglycerides \<2.3 mmol/l
* Normal liver function (assessed by measuring liver enzymes in the screening blood sample).
* Blood pressure lower than BP \<140/90 mmHg.
* Not suffering any cardiovascular diseases/ heart diseases e.g. stroke in the past 12 months.
* Do not suffer from chronic gastrointestinal problems (e.g. Inflammatory Bowel Disease, Irritable Bowel Syndrome, coeliac disease)
* Do not take supplements or medication that effects gastrointestinal health
* Not participated in a pre-/probiotic or laxative trial within the previous 3 months.
* Not been prescribed and/or taken antibiotics in the previous 6 months.
* No history of alcohol misuse based on self-reported alcohol intake and measurement of liver enzymes in the screening blood sample.
* Have history of food intolerances/allergies (e.g. gluten or dairy) or intolerances (e.g. lactose).
* Taking, or unwilling to stop taking anti-oxidant supplements (e.g. vitamin C, vitamin E, Multivitamin tablets, polyphenol supplements)
* Received antibiotics in the previous 6 months.
* Have participated in similar dietary or prebiotic/probiotics study in the previous 3 months.
* Current smoker.
Exclusion Criteria
* Been diagnosed with gastrointestinal disorders (e.g. Inflammatory bowel disease, irritable bowel syndrome, coeliac disease)
* Adherence to a dietary pattern which excludes foods from an animal origin.
18 Years
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Quorn
INDUSTRY
Northumbria University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
daniel M commane, PhD
Role: PRINCIPAL_INVESTIGATOR
Northumbria University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northumbria University
Newcastle upon Tyne, Tyne and Wear, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Farsi DN, Gallegos JL, Finnigan TJA, Cheung W, Munoz JM, Commane DM. The effects of substituting red and processed meat for mycoprotein on biomarkers of cardiovascular risk in healthy volunteers: an analysis of secondary endpoints from Mycomeat. Eur J Nutr. 2023 Dec;62(8):3349-3359. doi: 10.1007/s00394-023-03238-1. Epub 2023 Aug 25.
Farsi DN, Gallegos JL, Koutsidis G, Nelson A, Finnigan TJA, Cheung W, Munoz-Munoz JL, Commane DM. Substituting meat for mycoprotein reduces genotoxicity and increases the abundance of beneficial microbes in the gut: Mycomeat, a randomised crossover control trial. Eur J Nutr. 2023 Apr;62(3):1479-1492. doi: 10.1007/s00394-023-03088-x. Epub 2023 Jan 18.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NorthumbriaU001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.